chr6-116616648-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001010892.3(RSPH4A):c.25C>A(p.Gln9Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,613,582 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001010892.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RSPH4A | NM_001010892.3 | c.25C>A | p.Gln9Lys | missense_variant | 1/6 | ENST00000229554.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RSPH4A | ENST00000229554.10 | c.25C>A | p.Gln9Lys | missense_variant | 1/6 | 1 | NM_001010892.3 | P1 | |
RSPH4A | ENST00000368581.8 | c.25C>A | p.Gln9Lys | missense_variant | 1/5 | 1 | |||
RSPH4A | ENST00000368580.4 | c.25C>A | p.Gln9Lys | missense_variant | 1/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151988Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000560 AC: 14AN: 250066Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135240
GnomAD4 exome AF: 0.000139 AC: 203AN: 1461594Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 98AN XY: 727062
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151988Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74246
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Dec 25, 2021 | This sequence change replaces glutamine, which is neutral and polar, with lysine, which is basic and polar, at codon 9 of the RSPH4A protein (p.Gln9Lys). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with RSPH4A-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 27, 2015 | The p.Q9K variant (also known as c.25C>A), located in coding exon 1 of the RSPH4A gene, results from a C to A substitution at nucleotide position 25. The glutamine at codon 9 is replaced by lysine, an amino acid with similar properties. This variant was previously reported in the SNPDatabase as rs139499008. Based on data from the NHLBI Exome Sequencing Project (ESP), the A allele has an overall frequency of approximately 0.02% (3/13006) total alleles studied and 0.03% (3/8600) European American alleles. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of p.Q9K remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at